Intended for licensed healthcare professionals located in Denmark.
Read the compulsory information here – Denmark abbreviated prescribing information
ICLUSIG
Home
View expert videos
on ICLUSIG
ICLUSIG
resources
Because Tomorrows Matters Today
Blue square
Resources for ICLUSIG

Learn more about the treatment
for CML and Ph+ ALL

ICLUSIG has been with you since 2013. With over a decade of combined experience and data, we've built confidence that ICLUSIG may improve patients' futures.1,2
10-year icon

ICLUSIG HERITAGE INFOGRAPHIC

Want to discover more about the combined experience and efficacy and safety data with ICLUSIG? Click through the concise and informative ICLUSIG infographic below.

Watch a series of short videos
where experts tell the ICLUSIG story
Click here

Abbreviations: CML, chronic myeloid leukaemia; Ph+ ALL, Philadelphia chromosome-positive acute lymphoblastic leukaemia.

References: 1. Cortes JE, et al. Blood. 2018;132:393–404; 2. Cortes J, et al. Blood. 2021;138:2042–50.

Privacy Policy Cookie Policy Terms of Use

Please refer to the product information of your home country for more information.

DK/ICLG/P/24/0010
Date of preparation: September 2024

© 2024, Incyte. All rights reserved.
Marketing authorisation holder: Incyte Biosciences Denmark ApS.
ICLUSIG, the ICLUSIG logo and the Incyte logo are registered trademarks of Incyte.

If you would like to request further medical information, please visit:
www.incyteglobalmedicalinformation.com